This article uses mathematical models to investigate the consequences of noninstantaneous choice between two prey types by a predator. The models are characterized by three features: sustained cycles in predator and prey population sizes, a trade-off between the predator's consumption rates of the two prey and adaptive adjustment of the consumption rates at a rate proportional to the change in predator fitness per unit change in consumption rates. Adaptive adjustment of consumption rates frequently prevents the system from achieving an ideal free distribution of predator foraging effort and frequently results in chaotic dynamics or alternative attractors. The process of switching to consume the more common prey can reduce the minimum density of one or both prey. These phenomena occur for a variety of different models, including models in which both prey are in the same or in distinct habitats. An ideal free distribution can often be attained by adding prey refuges or immigration, provided these have a large enough effect on the dynamics of the system. The dynamics of switching can be important in determining indirect interactions between prey species and other aspects of food web dynamics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/303154 | DOI Listing |
JAMA Netw Open
December 2024
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Importance: Commercial prices for hospital care are high and vary widely in the US. Employers and state policymakers are exploring reference-based pricing (RBP) to set their payment rates as multiples of Medicare prices; understanding the range of commercial price variation within a hospital is important for calculating the appropriate price targets that are effectively low to generate savings but also feasible and viable to local hospital markets.
Objective: To examine within-hospital maximum-to-minimum commercial hospital price gaps negotiated by 5 national insurers and estimate plan savings if the minimum prices within each hospital are used as new payment level.
Eur J Clin Pharmacol
December 2024
Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Purpose: This study aimed to systematically review the cost-effectiveness of rivaroxaban plus aspirin (RIV + ASA) versus aspirin (ASA) alone in patients with stable coronary artery disease (CAD) or peripheral artery disease (PAD).
Methods: A systematic review was conducted using leading databases including PubMed, Scopus, and Web of Science core collection. The search was carried out up to June 25, 2024, focusing on identifying full economic evaluation studies comparing the cost-effectiveness of RIV + ASA versus ASA alone in patients with stable cardiovascular diseases (CVDs).
J Manag Care Spec Pharm
December 2024
Health Economics and Value Assessment, Sanofi, Boston, MA.
Background: Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening thrombotic microangiopathy. Caplacizumab is the only treatment approved by the European Medicines Agency and the US Food and Drug Administration for iTTP, to be given in combination with plasma exchange therapy (PEX) and immunosuppression (IS). The National Institute for Health and Care Excellence's independent appraisal committee assessed the cost-effectiveness of caplacizumab and concluded that the addition of caplacizumab to PEX+IS is cost-effective under a patient access scheme in the United Kingdom.
View Article and Find Full Text PDFACS Omega
December 2024
College of Energy Engineering, Zhejiang University, Hangzhou 310027, PR China.
Nano-AlO derived from recyclable sources emerges as a promising sustainable solution for enhancing diesel engine efficiency while mitigating emissions. However, a lack of an in-depth understanding of the health hazard aspect still challenges its commercial applications. To this end, nano-AlO/diesel (NAD) blends prepared via ultrasonic homogenization were experimentally and analytically investigated under various injection timings and excess air coefficients to explore the potential of nano-AlO for balancing energy performance and emissions.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
December 2024
Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Background: Thyroid cancer (TC) is a prevalent malignant tumor of the endocrine system in China. Current research primarily focuses on clinical diagnosis and treatment as well as underlying mechanisms, lacking epidemiological studies on the burden of the disease in China and worldwide.
Methods: The Global Burden of Disease Study 2021 was utilized to assess the incidence, prevalence, death, and disability-adjusted life years of TC in China and worldwide from 1990 to 2021 using the Joinpoint and R software.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!